Sign in

    Adam Chazan • TD Cowen

    Adam Chazan is Managing Director at TD Cowen, specializing in healthcare investment banking with a particular focus on the tools and diagnostics sector. He leads advisory and execution for high-growth and disruptive companies within diagnostics and medical technology, bringing expertise from previous roles as Global Co-Head of Medical Technology Investment Banking at Bank of America and leadership positions at Leerink Swan, Merrill Lynch, Pacific Growth Equities, ING, and William Blair. Chazan joined Cowen in 2021 after a decade at Bank of America and has established a strong professional reputation for managing complex transactions and client relationships in healthcare banking. He holds relevant securities licenses, as expected for senior investment bankers, and is recognized for his deep industry knowledge and network.

    Adam Chazan's questions to Owlet Inc (OWLT) leadership

    Adam Chazan's questions to Owlet Inc (OWLT) leadership • Q3 2024

    Question

    Adam Chazan inquired about the current state of the consumer environment and its effect on channel growth. He also asked about Owlet's geographic manufacturing exposure, the potential margin impact from new tariffs, the reimbursement path for BabySat with additional payers, and the international commercialization strategy for BabySat.

    Answer

    President and Chief Revenue Officer Jonathan Harris stated that the consumer environment remains strong, driven by recent FDA and CE clearances. Regarding BabySat, he noted that new DME partnerships are expanding insurance access and the company is building direct relationships with hospitals. On the topic of manufacturing, CFO Amanda Twede Crawford explained that while cameras are made in China, the primary Sock and Duo products are made in Thailand, and the company is exploring options like moving camera manufacturing to Vietnam to mitigate tariff risks. CEO Kurt Workman and Jonathan Harris added that the Sock and Duo's classification as medical devices has historically excluded them from tariffs.

    Ask Fintool Equity Research AI